Pediatric Endocrine Testing: Hormone Analysis, Methods, and Clinical Applications for Children

Pediatric endocrine testing is a specialized branch of clinical laboratory medicine that measures hormone levels, metabolic markers, and related analytes in infants, children, and adolescents to diagnose and manage growth disorders, thyroid dysfunction, puberty abnormalities, diabetes, and adrenal conditions. Because a child's endocrine system differs physiologically from that of adults, accurate testing requires age-specific reference intervals, validated low-volume analytical methods, and strict pre-analytical controls. This article provides a comprehensive technical overview of pediatric endocrine testing, including sample types, testing items, analytical methods, clinical applications, and frequently asked questions.

Technical Overview

The endocrine system in children is dynamic, changing dramatically from the neonatal period through infancy, childhood, and puberty. Hormone concentrations that are normal for a newborn may be pathological in a school-aged child, and vice versa. Pediatric endocrine testing therefore encompasses the quantitative measurement of hormones, binding proteins, metabolic intermediates, and regulatory factors in biological specimens collected from patients under 18 years of age.

Unlike general clinical chemistry, pediatric endocrine testing faces unique technical challenges. Sample volumes are often limited, particularly in neonates and toddlers, which demands high-sensitivity analytical platforms capable of producing reliable results from micro-volume specimens. Many hormones exhibit pulsatile secretion (such as growth hormone) or circadian rhythms (such as cortisol), requiring timed collections or dynamic stimulation and suppression tests. Additionally, sex steroid levels in prepubertal children are extremely low, often below the detection limits of conventional immunoassays, which is why liquid chromatography-tandem mass spectrometry (LC-MS/MS) has become increasingly important in this field.

Laboratories performing pediatric endocrine testing should operate under a quality management framework consistent with ISO 15189 (Medical laboratories — Requirements for quality and competence) and follow method validation and reference interval establishment practices aligned with CLSI guidelines. Accredited third-party laboratories and hospital clinical laboratories typically partition reference intervals by age and sex, and by pubertal (Tanner) stage where applicable, to ensure clinically meaningful interpretation.

Testing Samples

Serum and Plasma (Venous Blood)

Serum or heparinized/lithium-heparin plasma collected by venipuncture is the primary specimen for most hormone assays, including thyroid function panels, growth-related factors, gonadotropins, and adrenal steroids. Small-volume pediatric collection tubes (microtainers) are commonly used to minimize blood draw volume. Morning collection is often specified for cortisol and testosterone due to diurnal variation.

Dried Blood Spots (DBS)

Dried blood spot specimens, obtained by heel or finger prick onto filter paper, are the standard matrix for newborn screening programs. They enable detection of congenital hypothyroidism (TSH), congenital adrenal hyperplasia (17-hydroxyprogesterone), and other endocrine-metabolic conditions within the first days of life, requiring only a few drops of blood.

Urine

Timed or 24-hour urine collections are used for measuring urinary free cortisol, catecholamines and metanephrines, calcium, phosphorus, and creatinine. First-void or random spot urine with creatinine normalization is a practical pediatric alternative when 24-hour collection is not feasible.

Saliva

Salivary cortisol, collected by passive drool or swab devices, offers a non-invasive option for assessing free (bioavailable) cortisol, particularly for late-night sampling in suspected Cushing syndrome in older children and adolescents.

Capillary Blood

Finger-prick capillary blood is used for point-of-care glucose, ketone, and HbA1c monitoring in children with diabetes mellitus, supplementing venous laboratory measurements.

Testing Items

Typical pediatric endocrine panels cover hormones and related biomarkers grouped by functional axis:

• Growth axis: growth hormone (GH), insulin-like growth factor 1 (IGF-1), insulin-like growth factor binding protein 3 (IGFBP-3), GH-binding protein, and dynamic GH stimulation test responses using arginine, clonidine, glucagon, or insulin tolerance testing.
• Thyroid axis: thyroid-stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3), total T4, total T3, thyroglobulin, anti-thyroid peroxidase (anti-TPO) antibodies, anti-thyroglobulin antibodies, and TSH receptor antibodies (TRAb).
• Hypothalamic-pituitary-gonadal axis: luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, testosterone, dehydroepiandrosterone sulfate (DHEAS), androstenedione, inhibin B, anti-Müllerian hormone (AMH), and prolactin.
• Adrenal axis: cortisol, adrenocorticotropic hormone (ACTH), 17-hydroxyprogesterone (17-OHP), 11-deoxycortisol, aldosterone, renin activity or direct renin concentration, and 24-hour urinary free cortisol.
• Glucose and metabolic regulation: fasting glucose, insulin, C-peptide, hemoglobin A1c (HbA1c), oral glucose tolerance test (OGTT), and autoantibodies (GAD65, IA-2, insulin autoantibodies, ZnT8) for type 1 diabetes evaluation.
• Bone and mineral metabolism: calcium (total and ionized), phosphorus, magnesium, alkaline phosphatase, intact parathyroid hormone (PTH), 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D.
• Water homeostasis: serum and urine osmolality, sodium, potassium, and vasopressin (ADH) for diabetes insipidus and SIADH workups.
• Catecholamine markers: plasma free metanephrines and urinary catecholamines/metanephrines, vanillylmandelic acid (VMA), and homovanillic acid (HVA) for neuroendocrine tumor screening.

Testing Methods

Method selection depends on the analyte, expected concentration range, required sensitivity, and available sample volume:

• Chemiluminescent immunoassay (CLIA) and electrochemiluminescent immunoassay (ECLIA): automated, high-throughput platforms used for TSH, FT4, LH, FSH, prolactin, cortisol, insulin, and ferritin. They provide short turnaround times and excellent precision at low sample volumes.
• Enzyme-linked immunosorbent assay (ELISA): plate-based immunoassays used for lower-volume specialty analytes such as inhibin B, AMH, and certain autoantibodies.
• Radioimmunoassay (RIA): historically important and still used in some settings for analytes like renin activity, though largely replaced by non-isotopic methods.

• Liquid chromatography-tandem mass spectrometry (LC-MS/MS): the reference-level technique for steroid panels (testosterone, estradiol, 17-OHP, aldosterone, cortisol), offering superior specificity and sensitivity at the very low concentrations found in prepubertal children. It is also the preferred method for second-tier newborn screening confirmation.

• Automated clinical chemistry: colorimetric and ion-selective electrode methods for glucose, electrolytes, calcium, phosphorus, and liver/kidney function markers supporting endocrine interpretation.
• HPLC and capillary electrophoresis: used for HbA1c quantification and hemoglobin variant detection in diabetes monitoring.
• Molecular and genetic testing: chromosomal microarray, karyotype, and next-generation sequencing panels for suspected monogenic endocrine disorders such as congenital hypopituitarism, pseudohypoparathyroidism, or familial short stature syndromes.
• Dynamic function tests: GH stimulation tests (arginine, clonidine, glucagon, or insulin tolerance tests), GnRH agonist stimulation tests for central precocious puberty, dexamethasone suppression tests, and OGTTs performed under medical supervision with serial timed sampling.

All methods should be verified for analytical performance in the pediatric range, including limit of detection, limit of quantification, linearity, precision, and accuracy, with method comparison against reference procedures where available. Laboratories accredited to ISO 15189 must document these validations and participate in external quality assessment (proficiency testing) schemes.

Applications

Pediatric endocrine testing supports diagnosis, monitoring, and treatment decisions across a broad spectrum of conditions:

• Growth disorders: evaluation of short stature, tall stature, growth hormone deficiency, and IGF-1 deficiency; serial monitoring during recombinant human GH therapy.
• Puberty disorders: diagnosis and differential classification of central (GnRH-dependent) and peripheral (GnRH-independent) precocious puberty, delayed puberty, and hypogonadism; monitoring during GnRH agonist treatment.
• Thyroid disease: newborn screening for congenital hypothyroidism, diagnosis of acquired hypothyroidism and hyperthyroidism including Hashimoto thyroiditis and Graves disease, and dose titration of levothyroxine or antithyroid medication.
• Diabetes mellitus: establishment of type 1 versus type 2 diabetes through autoantibody panels and C-peptide, ongoing glycemic monitoring with HbA1c, and screening for diabetic ketoacidosis with ketones and blood gas analysis.
• Adrenal disorders: newborn and infant screening for congenital adrenal hyperplasia, diagnosis of adrenal insufficiency, Cushing syndrome, and primary aldosteronism.
• Bone and mineral disorders: workup of rickets, vitamin D deficiency, hypocalcemia, hypercalcemia, primary hyperparathyroidism, and renal osteodystrophy.
• Pituitary and hypothalamic disease: comprehensive pituitary hormone testing before and after treatment of craniopharyngioma, other sellar masses, or traumatic brain injury.
• Obesity and metabolic syndrome: insulin resistance assessment, lipid profiling, and liver enzyme monitoring in overweight children.
• Neuroendocrine tumors: biochemical screening and follow-up of pheochromocytoma, neuroblastoma, and medullary thyroid carcinoma using metanephrines, catecholamine metabolites, and calcitonin.
• Sports and forensic medicine contexts: age- and sex-hormone profiling may support bone age correlation and maturity assessment in selected medico-legal evaluations.

FAQ

Why do children need endocrine testing?

Testing is indicated when a child shows signs such as abnormally slow or rapid growth, early or delayed puberty, unexplained weight change, excessive thirst or urination, chronic fatigue, goiter, abnormal blood glucose, or electrolyte disturbances. Early biochemical identification allows timely intervention during critical windows of growth and development.

Is fasting required before testing?

Glucose, insulin, C-peptide, and lipid panels require an 8-to-12-hour fast; water is permitted. Most hormone assays (TSH, FT4, LH, FSH, IGF-1) do not require fasting, but morning collection between 8 a.m. and 10 a.m. is recommended for cortisol and sex steroids because of diurnal variation.

How much blood is needed from a small child?

Modern immunoassay platforms can run single hormone tests on 20 to 100 microliters of serum, so a full endocrine panel typically requires only 2 to 5 mL of blood depending on the number of tests. Dried blood spot and saliva options further reduce the burden for newborns and toddlers.

What is a stimulation test and why is it performed?

Because hormones such as GH are secreted in pulses, a single random level cannot confirm deficiency. In a stimulation test, a pharmacological agent (arginine, clonidine, glucagon, or insulin) is administered under medical supervision, and blood is drawn at timed intervals to measure the peak response. A blunted response supports the diagnosis of hormone deficiency.

Are pediatric reference ranges different from adult ranges?

Yes, significantly. Many hormones vary by age, sex, and pubertal stage. For example, LH and estradiol are extremely low before puberty and rise sharply during Tanner stages 2 to 5, while TSH is transiently elevated in healthy newborns. Results must always be interpreted against validated pediatric reference intervals.

How long does it take to receive results?

Routine immunoassay panels are usually reported within 24 to 48 hours. LC-MS/MS steroid panels, specialized autoantibodies, and genetic tests may take several days to a few weeks. Dynamic stimulation tests require same-day serial sampling with results often available within one to three days.

Is the testing painful or risky?

The procedures are minimally invasive and safe. Venipuncture discomfort is brief, and trained pediatric phlebotomists use small-gauge butterfly needles or microtainer collection. Stimulation tests carry a small risk of hypoglycemia or nausea and are conducted with continuous monitoring by clinical staff, following established safety protocols.

Which quality standards apply to pediatric endocrine laboratories?

Accredited third-party laboratories and hospital laboratories should comply with ISO 15189 requirements, use methods validated for pediatric specimen volumes and concentration ranges, participate in external quality assessment programs, and follow CLSI guidance for reference interval definition and method comparison.